Hjem › Makuladegeneration › Tennessee
Makuladegeneration kliniske forsøg i Tennessee
7 studier for Makuladegeneration søger deltagere på steder i Tennessee.
Byer i Tennessee
Officiel studietekst (engelsk)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Charles Retina Institute, Germantown
RekruttererFase 2/3
Alder 50 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07440225A Study in Adults With Geographic Atrophy
- Tennessee Retina, PC, Nashville
RekruttererFase 2
Alder 60 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Tennessee Retina, PC, Nashville
- Vanderbilt Eye Institute, Nashville
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 18. sep. 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Vanderbilt Eye Institute, Nashville
RekruttererFase 2
Alder 55 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT066594454D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Tennessee Retina, Nashville
RekruttererFase 1/2
Alder 50 og opefter · Alle køn · Opdateret 21. aug. 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Southeastern Retina Associates, Hixson
- Southeastern Retina Associates (Site 095), Johnson City
- Southeastern Retina Associates, P.C., Knoxville
- og 1 flere
RekruttererFase 2/3
Alder 50 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT07496567Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Tennessee Retina, PC, Nashville
RekruttererFase 3
Alder 50 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT07064759Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.